Treatment: Report lays out radical road map for rare cancers
August 9, 2017
A radical new report offers the federal government a roadmap for addressing inequitable access to rare and less common cancer treatments. More than 52,000 people are diagnosed with rare or less common (RLC) cancers and an estimated 25,000 people die from the conditions every year in Australia. RLC cancers are defined as those with fewer than six cases, and six to 12 cases per year per 100,000 population respectively. The Rare Cancer Australia report recommends radical reforms to research and treatment funding models, including provisional Pharmaceutical Benefits Scheme listings and enrolling RLC cancer patients in clinical trials to investigate treatments for more common conditions.